Glass House Brands (GLAS) Return on Invested Capital (2021 - 2026)

Glass House Brands (GLAS) posted quarterly Return on Invested Capital of 0.22% for Q1 2026, down 119.93% quarter-over-quarter from 1.09% in Q4 2025.

Glass House Brands (GLAS) Return on Invested Capital (2021 - 2026) Analysis & Trends

Glass House Brands (GLAS) has reported Return on Invested Capital for 3 consecutive years, with 0.22% the latest figure, recorded in Q1 2026.

In Q1 2026, Return on Invested Capital changed N/A year-over-year to 0.22%; the TTM figure through Mar 2026 stood at 0.22% (changed N/A YoY), while the FY2025 annual figure was 0.13%, changed N/A from the prior year.
Return on Invested Capital fell to 0.22% in Q1 2026 per GLAS's latest filing, from 1.09% in the prior quarter.
Across five years, Return on Invested Capital topped out at 1.09% in Q4 2025 and bottomed at 0.22% in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Haleon	43.94 Bn	42.97 Bn	-	-
2	Teva Pharmaceutical Industries	42.95 Bn	39.30 Bn	2.15 Bn	0.00%
3	Zoetis	31.58 Bn	29.90 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn	0.00%
5	United Therapeutics	22.16 Bn	19.49 Bn	683.80 Mn	-
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn	0.00%
7	Neurocrine Biosciences	15.53 Bn	15.14 Bn	935.80 Mn	-
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn	0.03%
9	Dr Reddys Laboratories	10.11 Bn	9.95 Bn	-	-
10	Glass House Brands	833.73 Mn	815.17 Mn	15.77 Mn	-0.27%

Download Data